TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›NYT
NYT logo

NYT

NEW YORK TIMES CO

Next earnings Aug 4, 2026 · consensus $0.67 EPS, $759M rev

Last earnings +8.3% on 2026-05-06

Buy
$73.85
▲ +4.53%
$73.85▲ +34.38%
over 1Y
L $50.99H $85.86
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.5%
1W+7.7%
1M-1.8%
3M-13.8%
YTD+6.3%
1Y+34.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B
Valuation
Overvalued
Filings
Watch
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 16 analysts
Buy

The Times' digital-subscription engine is humming — revenue +9%, EPS +18%, debt-free — justifying its premium 35x multiple.

Revenue $2.82B · FY2025

The read

The fundamentals carry the rating, but the price is rich (~20% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

The New York Times has completed one of media's most successful digital transitions, and FY2025 shows the model compounding. Revenue grew 9.2% to $2.82B, net income rose 17.1% to $344M, and operating income jumped 22.9% to $432M (15.3% operating margin) as the high-margin digital subscription base scales. The filing breakdown is telling: digital subscription revenue grew 14.3% to $1.43B and digital advertising grew 20.0%, more than offsetting structural print declines (subscription print -3.2%, advertising print -5.4%). This is a recurring, direct-to-consumer model with strong pricing power and a widening lead in quality journalism plus bundle products (Cooking, Games, Wirecutter, The Athletic).

The balance sheet is pristine. Management states the company ended 2025 debt-free with roughly $1.2B of cash and marketable securities, and the qualified pension plans are overfunded by ~$76M — removing two historical overhangs. Operating cash flow surged 42.4% to $584M against trivial capex of $34M, producing abundant free cash flow. Capital returns accelerated accordingly: buybacks nearly doubled to $165M and dividends rose 33.2% to $110M, with management committing to return at least 50% of free cash flow and a February 2026 dividend hike to $0.23/quarter. ROE is a healthy 16.9%.

Is NYT a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~90d expiry
  • Long call 74 @ ~4.60 est
  • Short call 85 @ ~1.17 est
debit $343max +$757max −$343BE 77.43

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.07B$2.31B$2.43B$2.59B$2.82B
Gross profit—————
Operating income$268M$202M$276M$351M$432M
Net income$220M$174M$232M$294M$344M
Diluted EPS$1.31$1.04$1.40$1.77$2.09
Net margin10.6%7.5%9.6%11.4%12.2%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$11.9B
EV / EBITDA23.1
EV / Sales4.2
EV / FCF21.7
P / FCF21.7
PEG (trailing)2.07
Earnings yield2.9%
FCF yield4.6%

Quality & risk

ROIC (est.)14.9%
Free cash flow$551M
Total debt$247M
Net cash$8.45M
Piotroski F-Score8/8

Capital returns

Buyback yield1.4%
Dividend yield (est.)0.9%
Shareholder yield2.3%
Shares Δ YoY-0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Earnings results2026-05-06
  2. 10-Q Quarterly report2026-05-06
  3. 8-K Shareholder vote2026-04-23
  4. DEF 14A Proxy statement2026-03-13
  5. 10-K Annual report2026-02-27
  6. 8-K Earnings results2026-02-04
  7. 8-K Officer / director change2026-01-21
  8. 8-K Earnings results2025-11-05
  9. 10-Q Quarterly report2025-11-05

Recent filings

all on EDGAR ↗
4Period ending 2026-06-032026-06-05open ↗144Filing2026-06-03open ↗SCHEDULE 13GFiling2026-05-15open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗SCHEDULE 13GFiling2026-05-14open ↗4Period ending 2026-05-112026-05-12open ↗144Filing2026-05-12open ↗144Filing2026-05-12open ↗144Filing2026-05-11open ↗10-QPeriod ending 2026-03-312026-05-06open ↗8-KPeriod ending 2026-05-062026-05-06open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueC-
GrowthB+
ProfitabilityB+
Financial healthA-
MomentumB
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$59.01

Overvalued -20% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.09 × (8.5 + 1.5 × 13.2% growth) × 1.00 quality = 28.2× multiple. An estimate, not a price target.

50.9952-week85.86
Revenue
$2.82B
+9.2% YoY
Net margin
12.2%
ROE
16.9%
P/E
35.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.82B+9.2%
Net income$344M+17.1%
Operating income$432M+22.9%
Diluted EPS$2.09+18.1%
Cash & equivalents$255M+28.1%
Total assets$3.00B+5.5%
Stockholders' equity$2.04B+5.9%
Op.: 15.3%

Frequently asked

Is NEW YORK TIMES CO (NYT) a buy?
NYT currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. The Times' digital-subscription engine is humming — revenue +9%, EPS +18%, debt-free — justifying its premium 35x multiple.
What is NYT's fair value?
A Modified-Graham model based on NYT's SEC fundamentals estimates a fair value of about $59.01. It is an estimate from reported earnings, not a price target.
Is NYT overvalued or undervalued?
Against a Modified-Graham fair-value estimate, NYT currently appears overvalued relative to its SEC-grounded earnings power.
What is NEW YORK TIMES CO's quality score?
NYT scores 71.09630639006755/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000071691, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/21/2026, 8:45:18 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:45 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 4 sales

2026-06-03
Welch Jacqueline M
EVP and CHRO
Sell4.00K @ $74.14$297K
2026-05-12
KOPIT LEVIEN MEREDITH A.
PRESIDENT & CEO
Sell9.75K @ $78.00$761K
2026-05-12
Bardeen William
EVP, Chief Financial Officer
Sell4.12K @ $77.85$321K
2026-05-11
Perpich David S.
Director
Sell9.00K @ $77.06$694K
2026-05-11
Perpich David S.
Director
Gift500.00
2026-04-22
GOLDEN MARGOT
Director
Award2.28K
2026-04-22
GOLDEN ARTHUR S.
Director
Award2.28K
2026-04-22
Glaser Rachel C
Director
Award2.28K
2026-04-22
Brooke Beth A.
Director
Award2.28K

Held by tracked funds

Form 13F · SEC · quarterly
Berkshire HathawayWarren Buffett15.1M sh$1.27B
Renaissance Technologies2.76M sh$231M
Two Sigma Investments2.31M sh$193M
Bridgewater AssociatesRay Dalio (founder)159K sh$13.4M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Dividends

Quarterly
Yield (TTM)
1.4%
Annual / share
$1.00
Last ex-date
2026-07-08
Last amount
$0.23
ex 2026-07-08paid 2026-07-23$0.23
ex 2026-04-01paid 2026-04-16$0.23
ex 2026-01-06paid 2026-01-16$0.18
ex 2025-10-08paid 2025-10-23$0.18
ex 2025-07-09paid 2025-07-24$0.18
ex 2025-04-01paid 2025-04-17$0.18

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-06Beat +27.5% est▼ -1.15%8-K ↗
2026-02-04Beat +1.0% est▼ -5.70%8-K ↗
2025-11-05Beat +9.5% est▲ +7.65%8-K ↗
2025-08-06Beat +15.7% est▲ +12.14%8-K ↗
2025-05-07—▲ +3.77%8-K ↗
2025-02-05—▼ -9.01%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-09-12Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗
2021-05-28Sara JacobsSell$50.0K–$100KPTR ↗
2021-03-16Peter MeijerSell$15.0K–$50.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score71 vs 67
Revenue growth9.2% vs 7.5%
Net margin12.2% vs 10.0%
Return on equity16.9% vs 12.0%
P/E35.3 vs 26.2